Viewing Study NCT01733134

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-05-12 @ 6:26 AM
Study NCT ID: NCT01733134
Status: WITHDRAWN
Last Update Posted: 2024-11-20
First Post: 2012-11-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)
Sponsor: Maisel, Alan, M.D.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acute heart failure View
None emergency department View
None copeptin View
None adh antagonists View